Development of human serum DKK1 ELASA Kit

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037005

Enrollment

Unknown

Registered

2020-08-26

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Gold Standard:The pathology department diagnosed liver cancer

Index test:Serum&#32

DKK1&#32

content&#32

enzyme-linked&#32

aptamer&#32

adsorption&#32

test&#32

kit

Eligibility

Sex/Gender

All

Age

18 Years to 86 Years

Inclusion criteria

Inclusion criteria: 1) The age is between 18 and 86 years old. 2) Diagnosed with liver cancer, hepatitis, liver cirrhosis patients in our hospital 3) Volunteers were recruited from Huashan physical examination center.(normal liver biochemistry, no liver history, no viral hepatitis and no malignant disease.)

Exclusion criteria

Exclusion criteria: 1) The patient requests to suspend the test. 2) The patient's age, gender and other important personal information is lost. 3) Patients with other tumors.

Design outcomes

Primary

Measure	Time frame
Sensitivity;Specificity;Accuracy;AUC of ROC;	—

Countries

China

Contacts

Public ContactZhang Jun

Huashan Hospital affiliated to Fudan University

archsteed@163.com+86 13795382825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026